2012: Banner Year for New Drugs

Fueled by new cancer therapeutics, last year the annual new molecular and biological entity approval count from the U.S. Food and Drug Administration (FDA) saw its highest year since 1997. One-third of the novel products approved by the FDA’s Center for Drug Evaluation and Research (CDER) are used to treat cancers of the blood, breast, colon, prostate, skin and thyroid.

FDA approved

Some Children Lose Symptoms, Diagnosis of Autism

Some children who are accurately diagnosed in early childhood with autism lose the symptoms and the diagnosis as they grow older, a study supported by the National Institutes of Health has confirmed [1]. The research team made the finding by carefully documenting a prior diagnosis of autism in a small group of school-age children and young adults with no current symptoms of the disorder.

Autism?

Study Identifies Itch-specific Nerves

Scientists have been looking for itch-specific nerves for decades. New research from investigators at Johns Hopkins University and Yale University in the United States and several universities in China has identified sensory neurons in mice that are dedicated to relaying itchy sensations from the top layers of skin to the spinal cord [1].

Woman itching her back

CDC Reports Flu Widespread, Google Search Trends Alarming

According to new surveillance statistics released on Friday from the Centers for Disease Control and Prevention (CDC), forty-seven states in the U.S. are now reporting widespread influenza activity [1]. The virus, which first appeared in the Southeast, has reached epidemic levels.

U.S. Influenza-like illness Activity - Jan 5, 2013

Glaucoma Cases Expected to More Than Double by 2030

Glaucoma is a group of eye conditions that can damage the optic nerve of the eye, which carries visual information from the eye to the brain. Glaucoma is the leading cause of preventable blindness in the United States. This potentially blinding eye disease currently affects 2.7 million people nationwide. Recent projections from the National Eye Institute (NEI) suggest this number of glaucoma cases will more than double by 2030 [1].

Glaucoma vision